Inmunotek S.L.
Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS7
PHASE 3 / 2-37
RECRUITING6
READOUTS ≤12 MONTHS1
| TRIAL | PHASE | STATUS | CONDITION | N | PRIMARY COMPLETION |
|---|---|---|---|---|---|
| 10,000 MG01 + 10,000 T517 NCT04891237 |
P3 | Recruiting | Rhinitis, Allergic; Rhinoconjunctivitis | 180 | 2026-01 (+37 mo) |
| MM09-SLIM NCT05641272 |
P2/3 | Not yet recruiting | Allergic Rhinitis; Allergic Asthma | 90 | 2026-06-01 |
| 10,000 MG01 +10,000 T521 NCT04898283 |
P3 | Recruiting | Rhinitis, Allergic; Rhinoconjunctivitis | 180 | 2026-10 (+46 mo) |
| MM09-SIT-023 NCT04435990 |
P3 | Recruiting | Rhinitis, Allergic; Rhinoconjunctivitis | 150 | 2026-12 (+71 mo) |
| Oraltek-58 NCT07348302 |
P3 | Recruiting | Rhinitis; Rhinoconjunctivitis | 736 | 2029-04-27 |
| MM09-SIT-063 NCT07904052 |
P3 | Recruiting | Allergic Rhinitis; Allergic Rhinoconjunctivitis | 250 | 2029-07 |
| EP-088_MM09 NCT07904195 |
P3 | Recruiting | Allergic Rhinitis; Allergic Rhinoconjunctivitis | 250 | 2029-07 |